BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33503547)

  • 1. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
    Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
    Kazmi S; Herekar F; Sarfaraz S
    Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
    Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
    J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.
    Tholin B; Ghanima W; Einvik G; Aarli B; Brønstad E; Skjønsberg OH; Stavem K
    Br J Haematol; 2021 Aug; 194(3):542-546. PubMed ID: 34028814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
    Langer F; Kluge S; Klamroth R; Oldenburg J
    Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
    Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
    Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 versus HIT hypercoagulability.
    Warkentin TE; Kaatz S
    Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
    Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
    J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
    Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
    Asakura H; Ogawa H
    Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():145-147. PubMed ID: 32291094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
    Vagrecha A; Stanco J; Majeed S; Kouides P; Acharya SS
    Haemophilia; 2021 Jul; 27(4):e517-e519. PubMed ID: 33427345
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
    Shalhoub J; Lawton R; Hudson J; Baker C; Bradbury A; Dhillon K; Everington T; Gohel MS; Hamady Z; Hunt BJ; Stansby G; Warwick D; Norrie J; Davies AH
    Health Technol Assess; 2020 Dec; 24(69):1-80. PubMed ID: 33275096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.